{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:18:41Z","timestamp":1740136721043,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Primary nodal marginal B-cell lymphoma (NMZL) is rare and histologically very variable. Its large-cell presentation is difficult to distinguish from nodal diffuse large B-cell lymphoma (nDLBCL) due to the absence of specific markers for nodal marginal zone lymphomas in general.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using a comprehensive cohort of NMZLs and a control cohort of nDLBCLs, we conducted a methylome analysis on subgroups of both.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The methylomes were strikingly different between the cohorts but unexpectedly homogeneous within the NMZL cohort. This allowed us to describe the morphologic spectrum of NMZL in all its value ranges. The considerable overlap in growth pattern and cytology of NMZL with nDLBCL was explored morphometrically, leading to an operational tool for separating both by a simple measurement of cell size and nuclear size. This was integrated in a hierarchical approach, including a scoring system for the parameter growth pattern, follicular colonization, follicular dendritic network, IgD expression, and Ki-67 rate, and led to a proposal for a classifier that we present here.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This methylome-based study extends the morphological spectrum of NMZL towards large cell morphology and offers a conventional way to distinguish it from nDLBCL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae120","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:46:21Z","timestamp":1728297981000},"page":"277-289","source":"Crossref","is-referenced-by-count":0,"title":["Histomorphologic spectrum of nodal marginal zone lymphoma as defined by its methylome"],"prefix":"10.1093","volume":"163","author":[{"given":"Francesca","family":"Spada","sequence":"first","affiliation":[{"name":"Institute of Pathology, Ulm University , Ulm ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel , Kiel ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred C","family":"Feller","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Schleswig-Holstein , L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center, University Hospital T\u00fcbingen , T\u00fcbingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology , Stuttgart ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"F\u00fcrstberger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University , Ulm ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F E","family":"Barth","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University , Ulm ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-3662","authenticated-orcid":false,"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University , Ulm ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"2025021323430215200_CIT0001","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4"},{"issue":"7","key":"2025021323430215200_CIT0002","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia."},{"issue":"11","key":"2025021323430215200_CIT0003","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood."},{"issue":"9","key":"2025021323430215200_CIT0004","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med."},{"issue":"11","key":"2025021323430215200_CIT0005","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1182\/BLOOD.V87.11.4483.BLOODJOURNAL87114483","article-title":"Mantle cell lymphoma\u2014an entity comes of age","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood."},{"issue":"4","key":"2025021323430215200_CIT0006","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/his.12160","article-title":"Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers","volume":"63","author":"Bob","year":"2013","journal-title":"Histopathology."},{"issue":"5","key":"2025021323430215200_CIT0007","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology."},{"issue":"3","key":"2025021323430215200_CIT0008","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ajcp\/aqy144","article-title":"IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification","volume":"151","author":"Wang","year":"2019","journal-title":"Am J Clin Pathol."},{"issue":"10","key":"2025021323430215200_CIT0009","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia."},{"issue":"6","key":"2025021323430215200_CIT0010","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMra2102568","article-title":"Marginal-zone lymphomas","volume":"386","author":"Rossi","year":"2022","journal-title":"N Engl J Med."},{"issue":"suppl 1","key":"2025021323430215200_CIT0011","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1182\/blood-2019-127199","article-title":"Splenic marginal zone lymphoma: risk of transformation, clinico-biological features at transformation and prognosis","volume":"134","author":"Bastidas","year":"2019","journal-title":"Blood."},{"issue":"2","key":"2025021323430215200_CIT0012","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/BJH.17193","article-title":"Genome-wide DNA methylation analysis along the progression of gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type","volume":"193","author":"Dugge","year":"2021","journal-title":"Br J Haematol."},{"issue":"17","key":"2025021323430215200_CIT0013","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2015-12-624296","article-title":"Optimizing therapy for nodal marginal zone lymphoma","volume":"127","author":"Thieblemont","year":"2016","journal-title":"Blood."},{"issue":"12","key":"2025021323430215200_CIT0014","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/J.CCELL.2021.10.00","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"issue":"2","key":"2025021323430215200_CIT0015","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/s0046-8177(99)90273-3","article-title":"Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases","volume":"30","author":"Paulli","year":"1999","journal-title":"Hum Pathol."},{"issue":"1","key":"2025021323430215200_CIT0016","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","article-title":"Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases","volume":"132","author":"Salama","year":"2009","journal-title":"Am J Clin Pathol."},{"issue":"11","key":"2025021323430215200_CIT0017","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol"},{"issue":"21","key":"2025021323430215200_CIT0018","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1182\/blood-2012-01-404194","article-title":"Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas","volume":"119","author":"Kuo","year":"2012","journal-title":"Blood."},{"issue":"3","key":"2025021323430215200_CIT0019","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ajh.25694","article-title":"Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma","volume":"95","author":"Qian","year":"2020","journal-title":"Am J Hematol."},{"issue":"3","key":"2025021323430215200_CIT0020","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/ijc.2910470304","article-title":"Histomorphologic and immunophenotypic spectrum of primary gastro-intestinal B-cell lymphomas","volume":"47","author":"Mielke","year":"1991","journal-title":"Int J Cancer."},{"issue":"1","key":"2025021323430215200_CIT0021","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ijc.25663","article-title":"BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"129","author":"Flossbach","year":"2011","journal-title":"Int J Cancer."},{"issue":"4","key":"2025021323430215200_CIT0022","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/GCC.1150","article-title":"Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract","volume":"31","author":"Barth","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"issue":"1","key":"2025021323430215200_CIT0023","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1038\/s41598-017-05116-3","article-title":"Comparative gene-expression profiling of the large cell variant of gastrointestinal marginal-zone B-cell lymphoma","volume":"7","author":"Barth","year":"2017","journal-title":"Sci Rep."},{"issue":"10","key":"2025021323430215200_CIT0024","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2025021323430215200_CIT0025","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia."},{"issue":"1","key":"2025021323430215200_CIT0026","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00428-019-02712-8","article-title":"IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications","volume":"477","author":"Granai","year":"2020","journal-title":"Virchows Arch."},{"issue":"2","key":"2025021323430215200_CIT0027","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","article-title":"Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin","volume":"480","author":"Vela","year":"2021","journal-title":"Virchows Arch."},{"issue":"15","key":"2025021323430215200_CIT0028","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-Cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"issue":"4","key":"2025021323430215200_CIT0029","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/2\/277\/59618998\/aqae120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/2\/277\/59618998\/aqae120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T23:43:43Z","timestamp":1739490223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/2\/277\/7814560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,7]]},"published-print":{"date-parts":[[2025,2,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae120","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,10,7]]}}}